Rapport Therapeutics, Inc. RAPP Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s investment purchases?
- Rapport Therapeutics, Inc. (RAPP) reported investment purchases of $30.37M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s investment purchases changed year-over-year?
- Rapport Therapeutics, Inc.'s investment purchases decreased by 29.8% year-over-year, from $43.24M to $30.37M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s investment purchases?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s investment purchases has grown at a 114.3% compound annual growth rate (CAGR), from $77.22M to $354.78M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.